Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events
- Department of Medicine/Cardiology, McGill University, Montreal, Quebec, Canada
- Correspondence to: Allan David Sniderman
, Department of Medicine/Cardiology, McGill University, Royal Victoria Hospital, 687 Pine Avenue West, Room H7.22, Montreal, Quebec, Canada H3A 1A1; allansniderman{at}hotmail.com
Commentary on:
Context
Each very-low-density lipoprotein and low-density lipoprotein (LDL) particle contains one molecule of apolipoprotein B (apoB). Increased numbers of cholesterol-depleted LDL particles are common in patients with hypertriglyceridaemia, premature vascular disease, obesity and type-2 diabetes mellitus and much in vitro and in vivo evidence indicates cholesterol-depleted LDL particles are at least as atherogenic as larger, more cholesterol-replete LDL particles.1 Nevertheless, …
